These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11478488

  • 1. Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.
    Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH, Lin XZ.
    Dig Dis Sci; 2001 Jul; 46(7):1387-92. PubMed ID: 11478488
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M, Kitada K, Tokunaga N, Yoshida Y, Narusaka T, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S, Inagaki M.
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [Abstract] [Full Text] [Related]

  • 3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 4. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
    Itoi T, Shinohara Y, Takeda K, Nakamura K, Shimizu M, Ohyashiki K, Hisatomi H, Nakano H, Moriyasu F.
    Int J Mol Med; 2001 Mar; 7(3):281-7. PubMed ID: 11179508
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
    Ito R, Tamura K, Ashida H, Nishiwaki M, Nishioka A, Yamamoto Y, Furuyama JI, Utsunomiya J.
    Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
    [Abstract] [Full Text] [Related]

  • 6. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
    Itoi T, Takei K, Shinohara Y, Takeda K, Nakamura K, Horibe T, Sanada A, Ohno H, Matsubayashi H, Saito T, Watanabe H.
    Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
    [Abstract] [Full Text] [Related]

  • 7. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
    Chen CY, Shiesh SC, Wu SJ.
    Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
    [Abstract] [Full Text] [Related]

  • 8. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A.
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [Abstract] [Full Text] [Related]

  • 9. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.
    Lee JC, Lin PW, Lin YJ, Lai J, Yang HB, Lai MD.
    J Formos Med Assoc; 1995 Dec; 94(12):719-23. PubMed ID: 8541732
    [Abstract] [Full Text] [Related]

  • 10. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
    Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A.
    Ann Intern Med; 2007 Oct 02; 147(7):451-9. PubMed ID: 17909206
    [Abstract] [Full Text] [Related]

  • 11. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
    Lee CS.
    Eur J Surg Oncol; 1997 Jun 02; 23(3):233-7. PubMed ID: 9236898
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T.
    Cancer Chemother Pharmacol; 2009 Dec 02; 65(1):113-20. PubMed ID: 19404641
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of tumors originating from the bile ducts.
    Dondelinger RF, Kurdziel JC, Capesius C.
    Bull Soc Sci Med Grand Duche Luxemb; 1988 Dec 02; 125(2):5-14. PubMed ID: 3072111
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N, Grenert JP, Sahai V, Kakar S.
    Hum Pathol; 2010 Apr 02; 41(4):485-92. PubMed ID: 20040392
    [Abstract] [Full Text] [Related]

  • 15. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
    Hum Pathol; 2010 Nov 02; 41(11):1558-65. PubMed ID: 20621328
    [Abstract] [Full Text] [Related]

  • 16. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.
    Ten Haaft BH, Pedregal M, Prato J, Klümpen HJ, Moreno V, Lamarca A.
    Eur J Cancer; 2024 Mar 02; 199():113564. PubMed ID: 38266541
    [Abstract] [Full Text] [Related]

  • 17. Differential diagnosis of jaundice by endoscopic retrograde cholangiography.
    Safrany L.
    Acta Gastroenterol Belg; 1973 Dec 02; 36(12):711-24. PubMed ID: 4788303
    [No Abstract] [Full Text] [Related]

  • 18. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.
    Vollmer CM, Drebin JA, Middleton WD, Teefey SA, Linehan DC, Soper NJ, Eagon CJ, Strasberg SM.
    Ann Surg; 2002 Jan 02; 235(1):1-7. PubMed ID: 11753036
    [Abstract] [Full Text] [Related]

  • 19. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract.
    Chow NH, Huang SM, Chan SH, Mo LR, Hwang MH, Su WC.
    Anticancer Res; 1995 Jan 02; 15(3):1055-9. PubMed ID: 7645925
    [Abstract] [Full Text] [Related]

  • 20. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
    Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D.
    J Hepatobiliary Pancreat Surg; 2000 Jan 02; 7(4):426-31. PubMed ID: 11180865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.